Glenmark launches shot to treat severe allergic reactions in US market
According to a company statement, Glenmark Pharmaceuticals Inc., USA, an arm of the company, has launched the Epinephrine injection of strength 10 mg/10 mL (1 mg/mL) multiple-dose vial.